158 related articles for article (PubMed ID: 17926481)
1. [The clinical significance of cyclic citrullinated peptide antibodies: new data].
Novikov AA; Aleksandrova EN; Nasonov EL
Klin Med (Mosk); 2007; 85(8):4-9. PubMed ID: 17926481
[TBL] [Abstract][Full Text] [Related]
2. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
3. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
van Venrooij WJ; van de Putte LB
Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
[TBL] [Abstract][Full Text] [Related]
4. [New biomarkers for rheumatoid arthritis].
Hayashi N; Nishimura K; Kumagai S
Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of anti-citrullinated protein antibodies in the diagnosis and prognosis of rheumatoid arthritis].
Bas S
Rev Med Suisse; 2005 Mar; 1(10):674, 677-8, 680 passim. PubMed ID: 15828370
[TBL] [Abstract][Full Text] [Related]
6. Additional diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.
Vallbracht I; Helmke K
Autoimmun Rev; 2005 Jul; 4(6):389-94. PubMed ID: 16081030
[TBL] [Abstract][Full Text] [Related]
7. [New diagnostic and evaluative tests for rheumatoid arthritis].
Hayashi N; Nishimura K; Morinobu A; Kumagai S
Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271
[TBL] [Abstract][Full Text] [Related]
8. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
9. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis.
Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM
Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028
[TBL] [Abstract][Full Text] [Related]
10. Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.
Grootenboer-Mignot S; Nicaise-Roland P; Delaunay C; Meyer O; Chollet-Martin S; Labarre C
Scand J Rheumatol; 2004; 33(4):218-20. PubMed ID: 15370715
[TBL] [Abstract][Full Text] [Related]
11. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
12. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.
Lee AN; Beck CE; Hall M
Clin Lab Sci; 2008; 21(1):15-8. PubMed ID: 18335856
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis].
Ota T
Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407
[TBL] [Abstract][Full Text] [Related]
15. Anti-CCP Antibody, a Marker for the Early Detection of Rheumatoid Arthritis.
van Venrooij WJ; van Beers JJ; Pruijn GJ
Ann N Y Acad Sci; 2008 Nov; 1143():268-85. PubMed ID: 19076355
[TBL] [Abstract][Full Text] [Related]
16. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic performance of anti-cyclic citrullinated antibodies and IgM rheumatoid factor in rheumatoid arthritis].
Lemos A; Ramos MP; Furtado MJ; Carvalho C; Santos MJ; Silva JC; Ventura H
Acta Reumatol Port; 2007; 32(4):345-9. PubMed ID: 18159201
[TBL] [Abstract][Full Text] [Related]
18. [Anti-CCP antibody test: diagnostic and pronostic values in rheumatoid arthritis].
Tant L; Steinfeld S
Rev Med Brux; 2006; 27(2):95-8. PubMed ID: 16736847
[TBL] [Abstract][Full Text] [Related]
19. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
[TBL] [Abstract][Full Text] [Related]
20. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis.
Niewold TB; Harrison MJ; Paget SA
QJM; 2007 Apr; 100(4):193-201. PubMed ID: 17434910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
